Tag Archives: Joseph France

Cantor Fitzgerald Believes HCA Holdings (NYSE: HCA) Still Has Room to Grow

In a report released today, Joseph France from Cantor Fitzgerald reiterated a Buy rating on HCA Holdings (NYSE: HCA), with a price target of $115. The company’s shares opened today at $107.99, close to its 52-week high of $108.85. France

Cantor Fitzgerald Keeps a Buy Rating on MedEquities Realty Trust

In a report released today, Joseph France from Cantor Fitzgerald reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT), with a price target of $13. The company’s shares closed yesterday at $10.86. France noted: “We are reiterating our $13

Cantor Fitzgerald Sticks to Its Buy Rating for Sabra Healthcare REIT

In a report released today, Joseph France from Cantor Fitzgerald maintained a Buy rating on Sabra Healthcare REIT (NASDAQ: SBRA), with a price target of $25. The company’s shares opened today at $20.99. France noted: “We rate SBRA $25 price

Cantor Fitzgerald Keeps a Buy Rating on LTC Properties

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on LTC Properties (NYSE: LTC) today and set a price target of $45. The company’s shares opened today at $39.23. France said: “Updating 2018-19 outlook. We are adjusting our outlook slightly

Cantor Fitzgerald Sticks to Their Buy Rating for Sabra Healthcare REIT

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on Sabra Healthcare REIT (NASDAQ: SBRA) today and set a price target of $25. The company’s shares opened today at $19.70. France noted: “SBRA reported 1Q18 results that are above our

Global Medical REIT Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France reiterated a Buy rating on Global Medical REIT (NYSE: GMRE) today and set a price target of $10. The company’s shares opened today at $8.45. France noted: “Updating outlook. We are adjusting our 2018 estimates